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Effect of Intravenous Treatment with the Oxytocin Antagonist Atosiban on Circulating 
Progesterone in the Ewe  
 
Todd M. Ramboldt  
   
Effects of oxytocin on the ovine corpus luteum have been controversial for a 
number of years. The present study investigated the effects of atosiban, a combined 
oxytocin and vasopressin 1A antagonist, administered systemically to ewes on post estrus 
day 8 to 10. Atosiban was given in four bolus intravenous injections at 0, 60, 120 and 180 
minutes with blood sampling every 15 minutes from -60 through 480 minutes. 
Concentrations of serum progesterone ng/ml were measured via radioimmunoassay. A 
log10 transformation of progesterone values was conducted to account for the 
heterogeneity of variance of the values. During the treatment interval (0 to 240 minutes), 
log10 concentrations of progesterone were lower in ewes treated with 20 mg (0.99) than in 
the 5 or 10 mg treated groups (1.00; P < 0.05). Control ewes (P < 0.0001) differed from 
ewes treated with atosiban (5, 10 or 20 mg). During times greater than 240 minutes 
(hours 4 to 24), log10 concentrations of progesterone decreased in control ewes (1.04) and 
were lower in the ewes treated with 5, 10 or 20 mg (1.01) of atosiban (P < 0.005). There 
was also a significant difference (P < 0.05) when comparing the 20 mg group (1.01) to 
the ewes treated with 5 and 10 mg of atosiban (1.02). Over the entire sampling period, 
mean log10  progesterone concentrations were lower (P < 0.001) in ewes treated with 
atosiban (1.00) compared to the control group (1.05). Among doses of atosiban, log10 
concentrations of progesterone were lower (P < 0.0001) in ewes treated with 20 mg 
(0.99) atosiban than in ewes treated with 5 mg or 10 mg (1.01) atosiban. The overall 
effect of systemic treatment with atosiban in this study was to decrease mean log10 
concentrations of progesterone relative to control ewes, which is in agreement with 
earlier findings using intraluteal infusion.  The most effective dose of atosiban was 20 
mg. In conclusion, systemic treatment with atosiban decreased concentrations of 
progesterone during the treatment phase of the experiment. Atosiban delivered in 20 mg 
maintained the lowest values in contrast to the control ewes and ewes treated with 5 or 10 
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In most spontaneous ovulators, the period of sexual receptivity in females is 
referred to as standing heat or estrus (Heape, 1900). Twenty-four to 30 hours after estrus 
a surge of luteinizing hormone (LH) (Bindon et al., 1979; Quirke et al., 1979) causes 
ovulation of the preovulatory follicle and onset of luteinization (Warbritton, 1934; 
McClellan et al., 1975; Parry et al., 1980; Murphy, 2000). Luteinization is the 
morphological and biochemical remodeling process that forms a transient organ known 
as the corpus luteum (CL) (Murphy, 2004). 
Fabricius (1604) and Adelmann (1672) first described the CL as “numerous little 
glands” on the porcine ovary. Research on the CL has focused on three main stages: 
growth (luteinization), maintenance, and regression (luteolysis) (Murphy, 2000). The 
most important hormone in reproduction and the hormone secreted from the CL in the 
largest amount during the maintenance phase is progesterone (Murphy, 2000; Sangha et 
al., 2002). Large luteal cells in the CL are responsible for secretion of the majority of 
progesterone of the ewe (Fitz et al., 1982). 
 Oxytocin was first discovered by Sir Henry Dale (1906) when he found that 
human posterior pituitary glandular tissue contracted the uterus of a pregnant cat. Dale 
named this neuropeptide “oxytocin” meaning swift birth (Viero et al., 2010). Oxytocin is 
produced not only in the hypothalamus and delivered via the posterior pituitary gland (du 
Vigneaud 1956; Viero et al., 2010), but also in large luteal cells of the CL (Wathes and 
Swann, 1982). Receptors for oxytocin have been localized in the uterus (Soloff et al., 




Wathes 1989), oviduct (Ayad et al., 1990) and cervix (Ayad et al., 1991).  Receptors have 
been found recently on small luteal cells of the CL in the ewe (Niswender et al., 2007). 
Hence, researchers have studied effects of oxytocin on estrous cycle length, secretion of 
progesterone by the CL and luteolysis. 
 Armstrong and Hansel (1959) reported that treatment, depending on the stage of 
the cycle with oxytocin had an effect on estrous cycle length in the cow. Daily injections 
initiated before day seven shortened the diestrous phase of the cycle. However, if daily 
injections began after day 15, the estrous cycle and continued unabated beyond estrus, the 
subsequent cycle was shortened. Milvae and Hansel (1980) found that giving 
subcutaneous injections of oxytocin on days four through six reduced jugular 
concentrations of progesterone on day eight. 
In an attempt to investigate further the effects of oxytocin on the CL, Mankey 
(2009) examined the effects of a combined oxytocin and vasopressin 1A receptor 
antagonist, atosiban, on the response of the ovine CL to exogenous prostaglandin F2!. 
Atosiban was delivered directly into the CL via a mini-osmotic pump. None of the four 
doses ( 0.25, 1.25. 2.50 or 5 µg/h ) of atosiban altered the response of serum progesterone 
to an injection of PGF2! or affected the weight of CL treated with PGF2! or vehicle 
when compared to reference ewes. However, concentrations of progesterone before 
treatment with PGF2! appeared to be reduced. In a subsequent experiment, 
concentrations of progesterone were decreased during the 48-hour sampling period when 
5 !g/h of atosiban was delivered continuously by the mini-pump. Hence, the first 
objective of this study was to determine if a series of four bolus intravenous injections of 




objective was to determine if there was a dosage effect on serum progesterone when 0, 5, 
10, or 20 mg of atosiban were injected intravenously. If atosiban were effective by the 
systemic route, a further objective was to examine changes in other hormones (LH and 
PGF2!) and genetic changes in the CL. 
Review of Literature 
Luteinization 
Luteinization can be described as a morphological and biochemical 
remodeling process that ensues after rupture of the preovulatory follicle and forms a 
transient ovarian organ known as the corpus luteum (CL) (Murphy, 2004). In this highly 
specialized process, two steroidogenic luteal cells are formed in response to the ovulatory 
stimulus (Warbritton, 1934; Murphy, 2000) from two endocrine cells in the follicle: 
granulosal and thecal cells. The granulosal cells are derived from mesothelial cells 
originating from the ovarian surface epithelium during embryonic formation of the 
ovarian follicles and become the large luteal cells (Juengel et al., 2002), which are 
generally spherical when viewed histologically. Corner (1937) established that granulosal 
cells were an integral part of the CL. The thecal cells, steroidogenic cells of the theca 
interna, become the small luteal cells, which are smaller in diameter (15.8 µm) compared 
to large to (29.2 µm) luteal cells in the ewe (Rodgers et al., 1984) and are distinguishable 
by a stellate appearance. 
Although outnumbered by the theca-derived, small luteal cells, the large 
luteal cells make up 25 to 35% of the volume of the CL (Nett et al., 1976; Rodgers et al., 




complexes, rough endoplasmic reticulum and secretory granules, and the small luteal 
cells have an in-folded nucleus (Schwall et al., 1986). This description applies for sheep 
(Warbritton, 1934), cattle (Meidan et al., 1990), and the ferret (Mead and Joseph, 1988). i 
The theca of the follicle can be separated into two parts: theca interna and theca 
externa. The theca interna contains the glandular thecal cells, connective tissue, and small 
blood vessels; whereas, the theca externa is connective tissue and smooth muscle-like 
cells that form the outer layer of the ovulating follicle (Warbritton, 1934). At ovulation, 
the follicle collapses, and a rapid influx of blood vessels, originating in the thecal layer, 
invade the antrum (Murphy, 2001). The granulosal cells of the developing follicle had 
functioned as a fused cell through intercellular gap junctions (Van Niekerk et al., 1975). 
Intercellular bridges are broken down during ovulation and reformed during luteinization. 
Reynolds and others (1999) suggested that there is intercellular communication in the 
luteal parenchyma based upon the expression of gap junctions during luteinization. In 
domestic ruminants, remodeling of the granulosal cells is very important in the formation 
and function of the CL. There is evidence that some of the small theca-derived luteal cells 
differentiate into large luteal cells (Cran, 1983; Alila and Hansel, 1984; Farin et al., 
1986).  
The processes of ovulation and subsequent luteinization occur in response to a 
surge of luteinizing hormone (LH) released from the anterior pituitary by gonadotropin-
releasing hormone (GnRH), which is released from the surge center of the hypothalamus. 
The surge causes a number of morphological and biochemical changes in the ovulatory 
follicle, such as an eight-fold increase in the volume of the granulosal cells by 




synthesis from estradiol 17-" to progesterone (Warbritton, 1934; Donaldson and Hansel, 
1965; McClellan et al., 1975; Parry et al., 1980; Murphy, 2000). Functional lutenization 
of both granulosal and thecal cells increased basal cAMP, secretion of progesterone, and 
involved morphological changes in the mitochondria in association with the increased 
intra cellular P-450scc (Richards et al., 1986; Rodgers et al., 1986). 
The two-cell, two-gonadotropin hypothesis proposed by Armstrong and 
Dorrington (1977) has been greatly supported in the rationale of follicular steroid 
conversion and production. In this proposal, the early steps of follicular steroidogenesis 
take place solely in the thecal layer with the conversion of cholesterol to progesterone 
and subsequently into androgens, more specifically androstenedione and testosterone. 
Androgens diffuse into the avascular granulosa where, under the influence of follicle-
stimulating hormone (FSH), they are converted by cytochrome p450 aromatase 
(Richards, 1980) to estrogens. The granulosal cells are remodeled by the differentiation-
dependent modification of the steroid pathway. 
 Steroid acute regulatory protein (StAR), the rate-limiting factor in steroid 
synthesis, transfers cholesterol from the cytoplasm to the inner mitochondrial membrane, 
where is it converted to pregnenolone via P450scc and 3"-hydroxysteroid dehydrogenase 
(Stocco, 2001). Both StAR and 3B-hydroxysteroid dehydrogenase are highly upregulated 
during luteinization and their presence decreases or practically disappears after CL 
regression (Chedrese et al., 1990; Albrecht et al., 2001).  
The combined shift in cells and proteins produces a shift of ovarian hormones.  




after ovulation there is a shift in the product to progesterone. Secretion of progesterone 
by the newly formed CL will be low during the first few days and elevated during the 
mid-luteal stage of the CL (Lipsett, 1978), because of increased uptake of cholesterol, the 
parent material for progesterone. The 3-hydroxy-3-methylglutaryl coenzyme A reductase 
(HMG-CoA) limits an early step in the synthesis of cholesterol (La Voie et al., 1997). 
Although present at all stages of the luteal cycle, HMG-CoA does not seem to be a major 
factor in the synthesis of progesterone from cholesterol (Plotkin et al., 2002). Two other 
sources of cholesterol are high-density lipoproteins (HDL), which are vital to rodents, 
and the low-density lipoproteins (LDL), which are more important in most other species 
(Murphy and Silavin, 1989). The receptors for lipoproteins are increased seven-fold 
during formation of the CL and contribute to the increase in progesterone production by 
the mid-luteal phase CL (La Voie et al., 1997, Rajapaksha et al., 1997; Li et al., 1998). 
During luteinization, cholesterol is transferred to the Golgi apparatus by a bulk 
cholesterol transfer protein know as Niemann-Pick, Type C1 protein (NPC-1) (Gevry et 
al., 2002). Two other mediators in the delivery of cholesterol to the CL are metastatic 
lymph node 64 protein (MLN-64) and StAR like-protein, which are located in the 
endosomes (Zhang et al., 2002). 
Corpora Lutea 
 Short (1977) reviewed the historical basis for depiction of the CL. De Graff was 
distinguished most for his description of the Graafian follicle, but he also provided the 
initial description of the CL. He described “globular bodies” that appeared on the ovary 
of rabbits after coitus and remained until after parturition and which gave an indication 




describing the cells that complete the CL in the ewe, but like other researchers during that 
time, she did not know all of the exact functions of the gland. 
The different stages of luteal maturity and differentiation bring about three 
different colors that can be observed by the naked eye on the ovaries of an exercised 
reproductive tract: red, yellow and white. Red is indicative of the corpus hemorrhagicum 
or “bloody body” that is formed immediately after ovulation. Yellow is associated with 
the functional CL; the gland was officially termed that, meaning yellow body. White 
refers to the corpus albicans or “white body” seen after the regression of the corpus 
luteum. The colors are attributed to Malpighi’s description of bovine ovaries in 1697 
(Adelmann, 1966).  
 Up until 1886, many scientists believed that the CL was just a scar that developed 
after ovulation. However, Knauer (1886) established through ablation-replacement 
studies that the ovary was a gland of internal secretion. Beard (1897) and Prenant (1898) 
hypothesized that the CL had specific functions in gestation, lactation, uterine 
development, and secreted substances into the blood stream. This early hypothesis was 
supported by Fraenkel (1903) and Magnus (1901), who isolated luteal hormones seven 
years after the experiments conducted by Beard and Prenant. The major advances in the 
field of reproductive physiology and more specifically luteal research came after the 
development of radioimmunoassays (RIA) to detect hormones in blood serum or plasma 
(Niswender and Midgley, 1970). The RIA was far more sensitive than the standard 




Three different lifespans of CL have been identified: long, short, and ultra short 
(Stouffer, 2006). The CL classified as long-lived would be those seen in canines; these 
animals are monoestrous species that have a prolonged cycle that can last from 2 weeks 
to 6 months (Rothchild, 1981; Concannon, 1986; Olson et al., 1989). In these species, the 
functional life span does not differ if the CL originated in a fertile or non-fertile cycle. 
Species with CL in this classification include dogs, wolves, foxes, skunks and cats 
(Eckstein and Zuckerman, 1956; Asdell, 1964) along with roe deer, armadillo and 
marsupials (Tyndale-Biscoe, 1973; Sharman, 1976; Hoffmann et al., 1978).  
The ultra short-lived CL are characteristic of rodents (Hilliard, 1973; Freeman, 
2006), in which a truly functional CL does not form unless mating occurs. Rodents do not 
have a true luteal phase and have estrous cycle lengths around 4 or 5 days. Females 
become pseudopregnant and keep the CL functional for 10 to 13 days when true 
pregnancy did not occur in response to mating (Gibori et al., 1988; Bowen-Shaver and 
Gibori, 2004). 
The focus of this review will concentrate on the short-lived CL, which occurs in 
polyestrous species, animals with frequent ovarian cycles such as primates and human 
beings. The lifespan of the CL is finite, around two weeks in those species, but is 
prolonged if pregnancy ensues. In primates, if fertile insemination occurs, this extended 
period allows for movement of the embryo into the uterus where it beings to implant 
(Stouffer and Hearn, 1998). A similar sequence of events occurs in ungulates, which 
include the domesticated farm animals such as cattle, sheep and goats. In this case, the 
CL forms rapidly after ovulation and will continue to function until days 15 to 21 




not occur, the functional CL will undergo luteolysis, and the estrous cycle will be 
repeated again. In the ungulates, follicular growth occurs during the luteal phase of the 
estrous cycle (Fortune, 1994). This early growth allows for rapid follicular growth after 
luteolysis, leading to another ovulation within two to three days. In contrast, the primate 
has less opportunity for antral follicle growth during the luteal phase, and subsequent 
ovulation and luteinization require about two weeks for the next ovulatory follicle to 
emerge (di Zerega and Hodgen, 1981; Zeleznik, 2001).  
 After completion of luteinization, two types of steroidogenic cells play vital roles 
in the secretory function of the CL. In addition to the large and small steroidogenic cells, 
there are other cell types that play an important role in the CL, including endothelial 
cells, smooth muscle cells, macrophages, leucocytes and pericytes (Alila and Hansel, 
1984). The CL secretes multiple hormones. Progesterone is the most recognized steroid 
hormone, along with small amounts of estradiol 17" in the case of sheep (Sangha et al., 
2002). The CL produces prostaglandin F2!, a hormone that plays a large part in 
luteolysis, and peptide hormones, including oxytocin, vasopressin, inhibin and relaxin 
(Fields, 1991).  
 Small and large luteal cells can be differentiated by immunocytochemistry and 
histochemistry (Fritz and Fitz, 1991; Sharma and Sharma, 1998). Large luteal cells 
represent approximately 40% of the volume of the CL in the goat, 33 to 38% in the sheep 
and 40% in the cow. Large luteal cells are around 10% of the total cell numbers in the CL 
in the goat, 8 to 14% in the sheep and 3.5% in the cow (Meyer, 1991). The large luteal 
cells in the ewe are characterized by a nucleus that contains a nucleolus and euchromatic 




volume of the CL in the sheep is made up of these cells, around 20% in the goat and 28% 
in the cow.  Of the total cell numbers, 23 to 36% are small luteal cells in the sheep, 
approximately 25% in the goat and 26% in the cow (Farin et al., 1986; Fields and Fields, 
1996; Sharma and Sharma, 1998). These small luteal cells contain smooth endoplasmic 
reticulum and mitochondria; however, they lack rough endoplasmic reticulum and 
secretory granules (Rodgers and O’Shea, 1982). The large luteal cells in the mature CL of 
the sheep have a 1.8-fold greater frequency of mitochondria per unit volume of cytoplasm 
compared to the small luteal cells; this indicates a higher metabolic investment in 
differentiation and development (Kenny et al., 1989). In addition, the large luteal cells are 
spherical (22 to 50 µm), and the small luteal cells are polyhedral, 12 to 22 µm in diameter 
(Rodgers and O’Shea, 1982; Singh and Prakash, 1988; Sharma and Sharma, 1998). In 
sheep, the newly-formed CL weighs as much as 600 to 700 mg in just a few days (Farin 
et al., 1986; Jablonka-Shariff et al., 1993). Steroidogenic activity can be related to the 
increase in the luteal cell diameter and will increase from days 6 to 8 and remain fairly 
constant until day 15, when regression (luteolysis) will begin (Cunningham et al., 1975; 
Juengle et al., 1993).  
 In the cow, luteal cell types have been termed type I and type II (Greenstein et al., 
1958) relative to their expected functionality. Experiments have been conducted to 
characterize further the two steroidogenic cell types in the ovine CL. The most 
outstanding difference in cell type is the diameter, which has been acknowledged in 
numerous species, including the cow and the sheep. Small and large cells were identified 





 In an early study, Fitz and others (1982) looked at the differences in the two cell 
types in the ewe. Ewes that were superovulated with human chorionic gonadotropin 
(hCG) were used in this experiment, and 5 to 17 corpora lutea per ewe were removed by 
midventral laparotomy. The tissue was sliced into 0.5 mm sections and was separated on 
a Beckman JE-6 elutriator rotor, equipped with a Sanderson chamber, into 4 separate 
fractions. Small luteal cells were contained mostly in fractions 2 and 3, and fraction 4 
was limited to predominately large luteal cells. The cells were analyzed for the rate of 





-dibutyryladenosine 3’-5’-cyclic monophosphoric acid (dbcAMP), and 
prostaglandins E2 and F2! (PGE2 and PGF2!). The secretion of progesterone was 20-fold 
greater in the large luteal cells than in the small luteal cells without stimulation. However, 
the responses to LH and dbcAMP in the small luteal cells were greater when compared to 
the large luteal cells. Large luteal cells had 3,074 receptors for LH/hCG and the small 
luteal cells had 33,260 receptors; whereas, the receptor sites for prostaglandins E2 and 
F2! were localized mostly in the large luteal cells (68,143 F2! and 10,995 E2). In 
contrast, the small luteal cells contained only 2,115 receptors for prostaglandin F2! and 
904 for prostaglandin E2. The results demonstrated a clear-cut distinction between the 
large and small luteal cells in the ovine CL. Progesterone appeared to be secreted 
generally by the large luteal cells and seemed to be independent of LH. The small luteal 
cells secreted small amounts of progesterone; however, they responded dramatically to 
LH or dbcAMP (Fitz et al., 1982). 
Progesterone secretion during late luteal phase of the estrous cycle is independent 




(Rodgers et al., 1984). McNeilly, Crow and Fraser (1992) looked at the effect of a 
gonadotropin-releasing hormone (GnRH) antagonist on episodic progesterone secretion 
or CL function in ewes. Scottish Blackface ewes were treated intra-muscularly with a 
GnRH antagonist at a rate of 1 mg per kg of body weight on day 4 or 11 of the luteal 
phase. Blood samples were collected at 10- or 15- minute intervals between 0 and 8, 24 
and 32, and 48 to 56 hours after the GnRH antagonist and daily from estrus for the 
duration of the 22-day treatment. Treatment with the antagonist beginning on day 4 of the 
luteal phase had no effect on luteal function until days 11 and 13, when progesterone was 
lower than the controls. Concentrations of FSH were unchanged by antagonist treatment 
on day 4 or day 11; however, no pulses of LH occurred in the treated ewes during the 
administration of the antagonist, and LH was suppressed for 3 days post treatment. The 
findings demonstrated that progesterone is released in an episodic manner from the CL 
and is independent of the secretion of LH until day 11. Suppression of LH for 3 days did 
not play a role in progesterone secretion or induce premature luteolysis (McNeilly et al., 
1992). 
Mechanisms that control the ovine CL were investigated in 1973 by a group of 
researchers in England and France with regard to DNA/RNA content, tissue weight and 
concentration of progesterone in ovarian venous blood (Denamur et al., 1973).  Ewes 
were between 12 to 14 months of age and were hysterectomized on days 9 to 12 of the 
estrous cycle. Twenty-seven animals were euthanized 27, 60, 128 and 135 days after 
hysterectomy. The fresh weight of the luteal tissue, content of DNA, RNA and the 
concentration of progesterone in ovarian vein blood were determined. In the other ewes, 




techniques were used to remove pituitary function; the first technique was a complete 
removal of the gland, and the other technique was to section the pituitary stalk and 
remove the adjacent pars tuberalis tissue. In hysterectomized ewes that received cortisol, 
(n = 37), CL were removed and studied at 24, 48, 72, or 96 hours or 12 days after 
hypophysectomy. Ewes in a second group (n = 84) were hysterectomized and were given 
cortisol daily following hypophysectomy; ewes in this group received FSH, LH, LH 
+FSH, prolactin + FSH, prolactin + LH or prolactin + FSH + LH by intramuscular 
injections or continuous intravenous infusion for 12 days.  
Following hysterectomy alone, weight of the CL remained constant until day 60 
and decreased by days 128 and 135 along with DNA and RNA. The progesterone content 
in the CL demonstrated that CL function was still maintained after hysterectomy through 
day 135. In ewes in which the pituitary was removed completely or the pars tuberalis was 
destroyed, the results differed among treatments. When the pituitary was removed, 
weight of the CL began to decline within 24 hours and continued to decrease rapidly for 
three days, then leveled off between days 3 and 12. Progesterone followed the same 
pattern in that the amount declined within 24 hours and by 72 hours was 5 to 7% of the 
controls. In ewes in which the pituitary stalk was removed and the pars tuberalis was 
destroyed, concentrations of progesterone, DNA and RNA and CL weight were not 
different than observed in the hypophysectomized ewes. Injections of prolactin (250 to 
1000 i.u/day) maintained the CL for 12 days after hypophysectomy, while 50 i.u/day was 
unable to maintain the CL. Combination treatments of .25/.5 mg of LH + prolactin were 




increase CL weight. Therefore, both prolactin and LH were considered necessary for the 
maintenance of the ovine CL. 
 However, Kaltenbach and others (1967) challenged the findings of Denamur’s 
group. They found that FSH, prolactin or estrogen did not demonstrate luteotrophic 
properties in hypophysectomized ewes and only constant infusion of crude LH 
maintained the CL. In incubated ovine luteal tissue, only the addition of LH increased 
progesterone concentration. The addition of FSH or prolactin had no effect on 
progesterone synthesis (Kaltenbach et al., 1967). Both groups concluded that pituitary 
support is necessary throughout the estrous cycle to maintain a functional CL 
(Kaltenbach et al., 1968). 
 The general actions of progesterone secreted by the CL are important to the 
maintenance of pregnancy. Progesterone acts on the reproductive tract to calm and 
prepare it for initiation and maintenance of pregnancy. The effects of progesterone are 
mediated through ligand-inducible transcription factors (Moutsatsou and Sekeris, 1997). 
Ligands control the expression of genes by binding to response elements on the DNA and 
previous exposure to estrogen induced the production of receptors for progesterone 
(Kraus and Katzenellenbogen, 1993; Kaneko et al., 1993; Ing and Tornesi, 1997). 
Progesterone receptors are required for progesterone to act on the reproductive tract. One 
action of progesterone is to down regulate the receptors for estradiol, thus blocking the 
mitogenic actions of estrogen (Brenner et al., 1974; Simpson et al., 1987; Fairchild and 




 During the follicular phase of the cycle, progesterone inhibited mitosis of the 
endometrium by blocking the estrogenic effect of inducing proliferation (Cummings and 
Yochim, 1984; Padykula et al., 1989). Progesterone also induced myometrial quiescence 
by increasing the resting potential and preventing coupling of the myometrial cells, which 
down regulated the voltage dependent calcium channels (Barta, 1986; Sharma and 
Buetter, 1993). Myometrial contractions are limited via progesterone blocking the ability 
of estradiol to induce !-adrenegic receptors (Bottari et al., 1983). 
Regulation of progesterone  
Gap junctions play a role in the regulation of progesterone secretion by ovine 
luteal cells. Gap junctions are contact-dependent pathways within the CL that are thought 
to be essential for the maintenance of the normal luteal tissue (Redmer et al., 1991; Del 
Vecchio et al., 1994; Redmer & Reynolds 1996 and Grazul-Bilska et al., 1997a, 1997b). 
Gap junctional intracellular communication is involved in many intracellular processes, 
including exocrine and endocrine signaling. Gap junctions facilitate transport of nutrients, 
ions and regulatory molecules between adjacent cells. Gap junctions play a role in 
regulation and coordination of luteal cells (Grazul-Bilska et al., 1997a , 1997b, Sohl & 
Willecke, 2004), and respond to systemic and local regulators of luteal tissue such as 
cytokines, second messengers, hormones and growth factors (Grazul-Bilska et al., 2001). 
LH and dbcAMP increase the rate of gap junctional intercellular communication between 
luteal cells and progesterone secretion (Redmer et al., 1991). The major connexin 
expressed within luteal cells during the estrous cycle is Cx43, which is localized in the 
borders of the luteal cell and forms gap junctional channels for the intercellular 




 Borowczyk and coworkers (2007) collected ovaries from superovulated ewes to 
obtain multiple CL per ewe. The ovaries were dissected, and corpora lutea were removed 
for testing in culture. These authors looked first at four concentrations of steroidogenic 
cells and their response to LH or dbcAMP. The CL was incubated for 24-hours, and the 
medium was collected and assayed for progesterone. Contact dependent gap junctional 
intercellular communication was determined by using a fluorescent dye and interactive 
laser cytometry. Immunohistochemistry was conducted to identify steroidogenic cells. 
The rates of gap junction intercellular communication and Cx43 mRNA expression were 
affected by the day of the estrous cycle, cell density and treatment. Progesterone 
secretion changed with changes in Cx43 mRNA expression, and the rates of gap 
junctional intercellular communication. The Cx43 mRNA was identified on the borders 
of all the luteal cells. These results demonstrated a positive correlation between 
progesterone secretion and Cx43 mRNA expression and gap junctional intercellular 
communication of luteal cells and that gap junctions are involved in steroidogenesis of in 
ovine CL (Borowczyk et al., 2007). 
 The effect of progesterone on estrous cycle length is very important. In the 
follicular phase of the cycle, concentration of progesterone is relatively low, whereas the 
concentration of estrogen is relatively high. Increasing concentrations of estradiol 17-" 
act via the hypothalamic-pituitary gonadal axis to stimulate low-amplitude, high-
frequency pulses of LH, which drive the Graffian follicle to ovulate (Lucy et al., 1992). 
After development of the CL, progesterone reduces the frequency of LH pulses and 
blocks the surge of GnRH from the hypothalamus (Attardi et al., 1992; Kawai and Clark, 




15 or 16, when secretion decreases as a result of luteolysis and the cycle will be repeated 
with a new ovulation. 
Luteolysis 
 Luteolysis is the cyclic regression of the CL and is caused by the episodic 
secretion of uterine PGF2!. This secretion can act locally on the CL or via systemic 
circulation (McCracken et al., 1999). Prostaglandin F2! is the major luteolytic hormone 
in sheep (McCracken et al., 1972) and is released from the uterus with small peaks 
recorded on day 12 and subsequent declines in progesterone (Scaramuzzi et al., 1974; 
Baird et al., 1975; Ottobre, 1979).  
Sharma and Fitzpatrick (1974) investigated the effect of estradiol-17" on 
prostaglandin F2! secretion in the anestrous ewe. Clun Forest ewes were assigned to four 
groups; each ewe received an intramuscular injection of estradiol-17" followed later by 
intravenous injections of oxytocin in two doses separated by one hour. The amount of 
estradiol varied among groups with group 1 receiving 0 µg, group 2, 50 µg and groups 3 
and 4, 1 mg. Oxytocin was given in paired doses of 0.4 followed by 2 units for groups 2 
and 3, or of 2 followed by 10 units for groups 1 and 4. Oxytocin was administered 24-
hours after estradiol injection. Posterior vena caval blood samples were collected every 6 
hours from 3 days before estradiol injection to 24 hours after and every 5 minutes for 30 
minutes and once again at 60 minutes after each oxytocin injection. Estradiol pre-
treatment increased concentrations of prostaglandin F2! in response to oxytocin. 
Oxytocin had no effect on concentrations of prostaglandin F2! when administered alone; 




within 5 minutes after the oxytocin injection, followed by a decline to low concentrations 
within 20 to 25 minutes post injection. When a second dose of oxytocin was administered 
an hour later, no further increase in the production of prostaglandin F2! occurred. The 
authors suggested that estrogen potentiated oxytocin-induced release of prostaglandin 
F2! from the uterus and that these injections may completely empty the prostaglandin 
F2! storage in the uterus, which may not be replenished within one hour (Sharma and 
Fitzpatrick, 1974). 
 Cooke and Ahmad (1994) conducted an experiment to determine if prostaglandin 
F2! induced the release of oxytocin from ovine CL in vitro. Luteal tissue was retrieved 
from euthanized Welsh Mountain ewes on day 6 or 12 after observed estrus, sliced and 
weighed. The tissue was preincubated for 45 minutes or 6 hours and then incubated for 
60 minutes in PGF2!. Six different concentrations of PGF2! ( 0, 1, 10, 100, 1000, or 
10000 nM ) were added to incubated tissue. The day-12 CL did not demonstrate a 
different response to the varying amounts of PGF2! or the length of the preincubation. In 
the day-6 CL, oxytocin was secreted in a dose dependent manner as the concentration of 
PGF2! increased. If incubation was extended the luteal cells secreted more oxytocin. The 
increased secretion of oxytocin from the day-6 CL supported the suggested hypothesis 
that more oxytocin was secreted during mid-cycle in the CL (Cooke and Ahmad, 1994). 
The ultrastructure and function of ovine CL in response to PGF2! treatment were 
investigated by Umo (1975). Ten Clun Forest ewes were detected in estrus by a 
vasectomized ram; the day the ewes were marked was designated as day 1 of the estrous 




were collected twice daily before 6 ewes were treated with 10 mg PGF2! i.m. on day 10, 
four times after the treatment at 3-hr intervals and once on the day after removal of the 
CL. The remaining ewes served as controls and received vehicle alone. Samples were 
assayed for concentrations of progesterone. The dose of PGF2! used had been found to 
be luteolytic (Douglas and Ginther, 1973). Twelve hours after the PGF2! injection, the 
ovaries of the ewes were removed and the CL were dissected and fixed. Histological 
slices were placed on wax. The ovaries of the control ewes were removed on day 15, and 
both control and treated ovaries were fixed for electron microscopy. Mean concentrations 
of progesterone fell from 4.8 + 0.2 ng/ml the day before treatment to 1.3 + 0.4 by 6 hours 
after PGF2! treatment, and continued to fall to 0.5 + 0.4, 12 hours after the injection of 
PGF2!. In ewes treated with PGF2!, there was an accumulation of lipid droplets and a 
decrease in the amount of smooth endoplasmic reticulum. A change in shape of the 
mitochondria and a decrease in the number of membrane-bound granules also were noted 
in the PGF2!-treated group (Umo, 1975). 
Oxytocin 
 Oxytocin is a central nervous system neuropeptide containing nine amino acids 
that was first discovered in 1906 by Sir Henry Dale, who found that human posterior 
pituitary glandular tissue extract contracted the uterus of a pregnant cat. With this new 
knowledge, he named the neuropeptide “oxytocin,” for swift birth (Viero et al., 2010). 
Vincent du Vigneaud was the first to sequence a peptide hormone, oxytocin, in 1953, and 
for his laboratory work was awarded the Nobel Prize in 1955 (du Vigneaud, 1956). This 




circulation via the neural lobe of the pituitary and in turn induced uterine contractions 
during parturition and milk ejection during lactation.  Oxytocin is the strongest uterotonic 
agent known and is commonly used to induce labor. An antagonistic analog to oxytocin, 
atosiban, is currently used to prevent preterm uterine contractions in women; that effect 
reflects the role for oxytocin in human labor (UKMi, 2001). 
 Oxytocin has other roles in the reproductive and social behaviors than just 
inducing uterine contractions. These roles include mediating social behaviors (Young et 
al., 1998), maternal behavior, sexual receptivity, and partnership bonding, so that some 
have concluded that oxytocin could be termed the “love hormone.” Oxytocin receptors 
are expressed in the pituitary, kidney, ovary, testis, heart, thymus, vascular epithelium, 
osteoclasts, cancer cells, adipocytes, myoblasts and pancreatic islet cells (Gimpl & 
Fahrenholz, 2001).  
 The proposed actions of oxytocin are all mediated through a single oxytocin 
receptor. The receptor is a seven transmembrane receptor and is a member of the class 1 
family of G protein-coupled receptors (Gimpl & Fahrenholz, 2001). These protein 
receptors include three vasopressin receptor subtypes, ( V1a, V1b, V2 ) and the oxytocin 
receptor. That forms a subfamily of structurally closely related receptors.  The members 
of this family, with exception of the V2 receptor, bond with  Gq/11 and activate 
phospholipase C in response to agonist binding (Ku et al., 1995).  
 During late gestation, the expression of the oxytocin receptor in the uterus is up 
regulated two fold, which results in a strong increase in uterine sensitivity to oxytocin 




decrease; however, oxytocin receptor expression in the mammary gland expression 
remained increased throughout lactation (Soloff et al., 1979; Brenton et al., 2001). Tissue 
specificity allows circulating oxytocin to target organs and specifically to induce milk 
ejection during lactation and uterine contractions during parturition. 
 Both ovine and bovine luteal cells synthesize oxytocin via a precursor protein 
similar to a protein found in the hypothalamus. Swann and colleagues (1984) collected 
bovine CL 5 to 10 days post-ovulation and sheep CL 3 days post-ovulation. The cells 
were isolated and incubated, and the hormones were detected using RP-HPLC. Oxytocin-
related components were isolated by immunoprecipitation with anti-oxytocin antiserum. 
Oxytocin was positively identified, via HPLC, as the hormone secreted by the ovine and 
bovine cells. Also, ovine cells appeared to synthesize more hormone than the bovine cells 
(Swann et al., 1984). Circulating concentrations of oxytocin and the patterns of its release 
vary during different stages of the estrous cycle. During the first 4 days after estrus, 
circulating oxytocin is low; at this time oxytocin stores in the old CL have been depleted, 
and synthesis is reinitiated in the preovulatory follicles (Wathes et al., 1993). Oxytocin 
release from the posterior pituitary can occur during this time of the cycle. These pulses 
have a duration of about 2 minutes at a frequency of 3 per hour (Gilbert et al., 1991). 
Oxytocin gene expression in the developing CL increases around the time of luteinization 
and release of oxytocin into circulation increases at this time. The concentration of 
oxytocin in CL rises between days 3 and 9 of the estrous cycle. In the ewe, concentrations 
of oxytocin increased until day 10, and a decrease was noted on that day (Jones et al., 
1988; Ivell et al., 1990). However, the concentration of oxytocin began to rise again 




endometrial oxytocin receptors are detected, allowing establishment of a positive 
feedback loop between the uterus and the ovary. Oxytocin-induced the release of 
prostaglandin F2! from the uterus, which, in turn, stimulated the release of oxytocin from 
the regressing CL (Flint and Sheldrick, 1983). 
 Use of iodinated oxytocin receptor antagonists allowed researchers to localize 
binding sites in the reproductive tract. Endometrium, myometrium (Roberts et al., 1985; 
Sheldrick and Flint, 1985; Ayad et al., 1984), oviduct (Ayad et al., 1990) and cervix 
(Ayad et al., 1991) all contain high affinity binding sites for oxytocin. There are low 
affinity binding sites in the ovary. Reports based on the human oxytocin receptor 
sequence supported the hypothesis that binding of oxytocin to its receptor activated a G-
protein that signals through calcium channels. The resultant stimulation of 
phospholipase-C increases turnover of inositol phosphates (Flint et al., 1986; Ott et al., 
1992). Increased turnover of inositol phosphate breaks down diacylglycerol to fatty acids, 
such as arachidonic acid, which is the rate-limiting precursor of prostaglandin F2! 
production. Thus, increasing availability of fatty acids, more specifically arachidonic 
acid, allows for PG-synthase to convert arachidonic acid to prostaglandins, and increased 
secretion of PGF2! can be measured by its metabolite 13,14-dihydro-PGF2! (PGFM). 
Oxytocin injections to cyclic ewes during the early and mid-luteal phase had no effect on 
PGFM. However, if oxytocin was injected on days 14 to 16 when estrogen was greater, 
an increase in PGFM was observed, with the maximum response to an injection on day 
15 (Fairclough et al., 1984; Silvia et al., 1992). 
 Further research was conducted to determine if oxytocin receptors are located in 




removed from the reproductive tract of 26 ewes during different stages of the estrous 
cycle, and the concentration of oxytocin receptors was determined by binding to 5 nmol/l 
oxytocin. Higher amounts of oxytocin receptors were found in cervical tissue only after 
day 15, and it peaked on the day of estrus (Matthews and Ayad, 1991). 
Portions of the reproductive tract were challenged with oxytocin at different times 
of the estrous cycle while recording electromyographic (EMG) activity. Oxytocin 
injected intravenously at 25, 50 and 100 mU resulted in mean peak plasma oxytocin 
concentrations of 2.2, 6.4 and 8.6 pg/ml with the values returning to baseline within 10 
minutes. Observed concentrations were similar to peaks occurring during a natural 
estrous cycle. The same procedure was conducted on ampulla, ampullary-isthmic 
junction, uterotubal junction, uterine horn, uterine body and cervix. The lowest dose of 
oxytocin, given at estrus, stimulated a response in all regions. Following estrus, the 
activity of the cervix and uterus was depicted by a coordinated muscle contraction that 
started at the cervix and proceeded to the uterotubual junction every 40 minutes. Thus, 
pituitary released oxytocin may regulate reproductive tract activity and could influence 
gamete and/or embryo transport (Garcia-Villar et al., 1982; 1983). 
Knowledge of actions of oxytocin in the ovary progressed rapidly after finding 
ovarian oxytocin receptors in several species. In nonpregnant women, oxytocin-binding 
sites (Fuchs et al., 1990) and oxytocin receptor mRNA (Kimura et al., 1992) were at the 
highest concentration in late luteal phase. Oxytocin positive staining in the ovarian 
stroma and theca interna was maximal during diestrus (Zhang et al., 1991). In the cow 
ovary, oxytocin staining was found in the stroma and CL with peak concentrations 




during mid-estrous cycle (Okuda et al., 1992). Oxytocin binding to luteal membranes and 
ovarian stroma was low throughout the estrous cycle in sheep (Wathes et al., 1992). 
Oxytocin is synthesized by the large cells of ovine CL (Rodgers et al., 1983; 
Jones and Flint 1988), and secretion is described as pulsatile during the luteal phase of 
the estrous cycle (Wathes, 1989). Swann and others (1984) demonstrated that bovine and 
ovine luteal cells synthesize oxytocin. The purpose of their experiment was to 
demonstrate how the luteal cells synthesize oxytocin by way of a precursor protein 
similar to one found in the hypothalamus. Bovine and ovine CL were collected, isolated 
and incubated with s-cysteine. Column separation and reverse-phase high performance 
liquid chromatography were used to determine the presence of oxytocin in luteal cell 
extracts. Less than 2 hours of incubation were required to recover labeled oxytocin and 
vasopressin. However, longer incubation showed peaks of radioactivity of both 
hormones. The results indicated that biosynthesis of luteal oxytocin involves the 
formation of a 14-kDA precursor protein that is cleaved to form oxytocin and 
neurophysin. Vasopressin was found in luteal tissue of both species, however, in smaller 
amounts when compared to oxytocin (Swann et al., 1984). 
 Many conflicting roles and suggestions about oxytocin have been offered. 
Cultured luteal cells have provided inconsistent results, and microdialysis systems have 
provided a different insight into the roles of oxytocin. Exogenous oxytocin induced an 
acute release of progesterone, and this release was blocked by the administration of an 
oxytocin antagonist in the cow (Miyamoto and Schams, 1991). The response to oxytocin 
was related to the availability of receptors and was maximal in early luteal phase (Fuchs 




 Mitchell and others (1982) investigated the release of oxytocin during the ovine 
estrous cycle, pregnancy and parturition in mixed-breed ewes. Daily carotid artery blood 
samples were taken prior to beginning the experiment to determine the stage of the 
estrous cycle of the nonpregnant ewes. Six pregnant ewes, fitted with a jugular catheter 
and divided into three groups and sampled on days 122 and 124, at term pregnancy days 
141 and 145 and during labor on days 146 and 148 of gestation. Of the two ewes in labor, 
one lambed during the sampling period and the other delivered 6 to 12 hours after the 
conclusion of the experiment. Oxytocin fluctuated acutely in the nonpregnant ewes 
during the two time periods: during the follicular phase and the early luteal phase. The 
pattern was more pronounced when the blood samples were collected at 1-minute 
intervals; oxytocin in the follicular phase was 39.2 + 1.5 and 36.7 + 1.3 (pg/mL) and 68.4 
+ 2.0 and 53.1 + 1.6 for the early luteal phase, with the differences between phases being 
significant. In the pregnant group, the average concentrations of oxytocin (pg/mL) were 
17 + 4, 8 + 3, 22 + 10, 22 + 8, 28 + 11, and 166 + 135, respectively, as gestation 
progressed. The outlier in the group was the ewe that delivered during the experiment. 
The authors concluded that the magnitude of oxytocin increased as the ewe approached 
parturition (Mitchell et al., 1982). 
 Trophoblast interferons can suppress development of oxytocin and estradiol 
receptors in the ovine endometrium. Interferon tau (IFN-t) signals maternal recognition of 
pregnancy (maintenance of CL) in sheep and cows (Lamming et al., 1995). This 
mechanism was investigated in Finn-Dorset ewes with one uterine horn isolated on day 6 
or 7 of their estrous cycle. The ewes were mated to a fertile or vasectomized ram and 




INF-t in the isolated horn; however, concentration of oxytocin receptors were high in 
both horns in ewes mated to the vasectomized rams. In ewes that conceived, a higher 
concentration of oxytocin receptors was found in the isolated non-pregnant horn 585 + 
131 fmol mg
-1
 compared to the pregnant horn that contained 45 + 11 fmol mg
-1.
 The 
pregnant horn expressed a significantly higher antiviral activity. Using in situ 
hybridization and an oxytocin antagonist, large amounts of oxytocin receptor message 
and binding sites were found in the endometrium of the isolated horn. 
Immunocytochemical studies demonstrated that there was a suppression of estradiol 
receptors in the pregnant horn when compared to the isolated horn. These findings 
indicated that INF-t plays a role in suppression of development of oxytocin and estradiol 
receptors in the endometrium of the pregnant ewe (Lamming et al, 1995). Further, INF-t 
extended luteal life span in ewes, when infused into the uterine vein (Bott et al., 2010). 
 Other studies have demonstrated that oxytocin in the ewe increased after day 15, 
and the peak concentration of oxytocin was on the day of estrus (Mathews & Ayad, 1991; 
Ayad et al., 1991). These data led researchers to determine the role of progesterone and 
estradiol 17" in regulation of uterine oxytocin receptors. Forty mixed breed ewes were 
ovariectomized and randomly placed into 8 groups. Four treatments were vehicle (corn 
oil) for 12 days, progesterone for 9 days, progesterone for 9 days followed by 
progesterone withdrawal until day 12, and progesterone for 12 days. The second subset of 
four treatment groups combined the effect of progesterone with estradiol 17-". Ewes 
received an intramuscular injection of progesterone or vehicle on day 1 at 0700h and 
1900h to mimic circulating progesterone concentrations in the mid-luteal phase of the 




axillary region of the ewes. The ewes were euthanized on day 10 or 13. Two other ewes 
were treated with an intravaginal sponge containing medroxyprogesterone acetate, and 
before sponge removal the ewes were injected on day 11 with 100 µg of estradiol 
subcutaneously. A second injection of estradiol was given on day 12, and the ewes were 
euthanized on day 13 for tissue collection. Blood samples (10 ml) were removed via 
jugular catheter daily at 1900h and the last sample was removed just before the ewes 
were euthanized. The blood samples were analyzed for progesterone and estradiol via 
radioimmunoassay.  
 Numbers of oxytocin receptors in the caruncular and intercaruncular endometrium 
did not differ between the two treatments. When estradiol was not included in the 
treatment with progesterone (9 or 12 days), concentration of the oxytocin receptors was 
reduced, which was similar to the estradiol withdrawal group and the control group. The 
presence of estradiol reduced concentrations of oxytocin receptor in the control and both 
the 9- and 12-day continuous progesterone treated groups; however, it increased the 
number of oxytocin receptors in the progesterone withdrawal group. These findings 
supported past studies (Ayad and Matthews, 1991; Ayad et al., 1991) of the pattern of 
oxytocin receptors during the natural estrous cycle in sheep with progesterone declining 
at the time of luteolysis and estrogen increasing in preparation for the LH surge and 
ovulation  (Zhang et al., 1992). 
  Forty-five ovariectomized Merino ewes were given exogenous 
progesterone and estrogen to mimic a normal estrous cycle (Lau et al., 1992). The 
objective of this experiment was to determine the effect of prostaglandin F2! response 




ewes were placed randomly into five treatment groups, group one served as a control, 
group 2 was pretreated with progesterone and estrogen, group 3 was pretreated and given 
progesterone for 12 days from day 1 with increasing doses of progesterone from 0.5 to 12 
mg, group 4 was given PGF2! twice a day at different dosages with respect to the day; 
0.5 mg on day 10, 1.0 mg on day 11 and 2.0 mg on day 12. The last group received both 
progesterone and PGF2! at those times. In experiment 1, all ewes were given an 
intravenous injection of 10 i.u of oxytocin at 0900 h on days 13 and 14 after estrus. The 
concentration of the metabolite of PGF2! (PGFM) was measured when blood samples 
were taken at -10, -5, 5, 10, 20, 30, 45 and 60 minutes around the time of the oxytocin 
injection. In the second experiment, ewes were hysterectomized on day 14, and uteri were 
analyzed for endometrial oxytocin receptors.  
    There was no detectable oxytocin-induced PGFM response to the steroid 
pretreatment. On day 14, the progesterone treatment alone, and the progesterone and 
PGF2!-treated groups each gave a significantly higher response when compared to the 
control ewes. Binding data were derived by using a Scatchard analysis and indicated that 
the highest concentrations of endometrial oxytocin receptors were in the untreated ewes. 
Progesterone and estrogen pretreatment did not change the concentration of endometrial 
oxytocin receptors; however, treatment with progesterone alone or in combination with 
PGF2! lowered the concentration of receptors. These results translate that as PGF2! 
increased, number of oxytocin receptors decreased (Lau et al., 1992). 
 Twelve heifers were fitted with a jugular cannula or an osmotic pump. Saline or 




heifers also received a challenge injection of oxytocin on day 16 of the estrous cycle. The 
objective of the experiment was to determine if a constant infusion of oxytocin would 
prolong the luteal phase and inhibit uterine prostaglandin F2! secretion in heifers. The 
method of administration did not have an effect on estrous cycle length or the pattern of 
progesterone secretion. However, the estrous cycle was significantly extended by 
oxytocin administration 25.3 + 0.4 days compared to 20.5 + 0.4 days in the control group. 
Luteolysis did not occur in oxytocin-treated heifers until the treatment had ended. In 
experiment 2, the results were similar when comparing the length of the estrous cycle; 
however, the challenge dose of oxytocin induced release of PGF2! in the saline-treated 
heifers, but not in the oxytocin-treated heifers (Lutz et al., 1991). 
Actions of oxytocin within the corpus luteum 
 Armstrong and Hansel (1959) looked at the effect of oxytocin on the CL and 
progesterone production. Once daily injections of oxytocin during the first seven days 
shortened the diestrus phase of the cycle; however, injections of oxytocin beginning on 
day 15 and continued through their normal estrous cycle shortened only the subsequent 
estrous cycle. Corpora lutea forming after the oxytocin treatments lacked size and 
number of luteal cells, which lead to their diminished function. Three oxytocin injections 
per day for the first ten days of the estrous cycle in heifers decreased the weight of the CL 
collected on day 11 and also decreased serum progesterone concentrations (Simmons and 
Hansel, 1964). Fairclough et al. (1984) found that at the end of the estrous cycle, pulses 
of PGF2! were simultaneous with pulses of oxytocin, which this was also true with 




 Other researchers have reported that oxytocin can function as a luteolytic agent.  
Twice-daily subcutaneous injections of oxytocin on days four through six reduced jugular 
progesterone levels by day eight in cattle (Milvae and Hansel, 1980a). However, when 
comparing the concentrations of PGF2! in the uterine vein and ovarian artery, an increase 
in concentrations of PGF2! occurred in the uterine vein 30 and 240 minutes after each 
injection of oxytocin, but was not detected in the ovarian artery. The transport of PGF2! 
from the uterine vein to the ovarian artery occurs by diffusion and takes 30 minutes 
(McCracken et al., 1972; McCracken et al., 1981; Hixon and Hansel, 1974). However, 
Milvae and Hansel (1980a) detected no local transfer of PGF2! from the uterine vein to 
the ovarian artery in oxytocin-treated ewes. An oxytocin infusion caused an increase in 
the concentration of PGF2! within 30 minutes in the ovarian arteries, which remained 
stable for 15 minutes (Bonnin et al., 1999).   
Vasopressin 1A 
Arginine vasopressin and oxytocin are structurally related, with only two amino 
acids sequences differing at the 3 and 8 positions, of a 20-membered ring. The primary 
role for vasopressin is regulation of renal and cardiovascular function. Antiduretic actions 
on kidney AVP-V2 receptors correct changes in blood osmolarity and its pressor actions 
on vascular smooth muscle. AVP-V1a receptors help maintain peripheral résistance 
under adverse conditions (Cowley, 1982; Kim et al., 1985). Hypothalamic arginine 
vasopressin thought via V1b receptors stimulate adrenocorticotropic hormone release 
from the pituitary (Antoni et al., 1984; Jard et al., 1986). Similar to oxytocin receptors, 




(Kimura et al., 1992; Morel et al., 1992; Hirsawa et al., 1994; Thibonnier et al., 1994; 
Rozen et al., 1995). Most arginine vasopressin V1a antagonists have been developed for 
treatment of hypertension and congestive heart failure (Yamamura et al., 1991).  
Nine multiparous Clun Forest pregnant ewes were used to determine the amounts 
of oxytocin and vasopressin in blood plasma and cerebrospinal fluid (Kendrick et al., 
1990). Blood samples were taken by jugular venipuncture and cerebrospinal fluid was 
taken from the lateral ventricle.  Animals were induced into labor by an injection of 
dexamethasone sodium phosphate (20 mg intramuscularly) on day 142. Three to five 
samples were taken before contractions began, 3 to 4 samples during visible contraction, 
and one sample immediately following the birth of the lamb and then at 15, 30, 60, 90 
and 120 minutes post-partum. Six of the nine ewes were sampled three months post 
parturition and 1 month after weaning. Ewes were given daily injections of estradiol 
benzoate for 48 hours and sampled immediately after vaginocervical stimulation. 
Stimulation consisted of rhythmically inserting and removing a plastic probe. Oxytocin 
and vasopressin concentrations were measured by radioimmunoassay.  
Concentrations of oxytocin in plasma and cerebrospinal fluid were significantly 
greater during contractions and birth (4.28 pmol/l) than during preparturition (1.9 pmol/l). 
Oxytocin concentrations were 2-fold greater in the cerebrospinal fluid than in plasma. 
Plasma concentrations of vasopressin were significantly elevated during contractions and 
birth, and for 15 minutes postpartum. After five minutes of mechanical vaginocervical 
stimulation an increase of oxytocin and vasopressin was found in cerebrospinal fluid and 




Atosiban and Barusiban 
Atosiban (ATO) or Tractocile is a mixed (V1a) and (OT) receptor competitive 
antagonist that has been developed for the treatment of preterm labor (PTL) contractions 
(UKMi, 2001). Ferring Pharmaceuticals developed this synthetic peptide in 1985 with the 
chemical structure being (1-deamino-D-Try(O-Et)-4-Thr-8-Orn)-Oxytocin) (Wellnitz et 
al., 1999). ATO was the first tocolytic developed and approved in Europe (Reinheimer, 
2007; Reinheimer et al., 2005), and it has been used with less adverse side effects, such 
as tachycardia, vomiting, headache, chest pain, fetal tachycardia and tremors (Wex et al., 
2009), than the Beta-mimetic agents (UKMi, 2001; Heus et al, 2008, 2009). The 
disadvantage of using ATO is the quick half-life and the rapid plasma clearance, with the 
initial half-life being 13 + 3 minutes and the terminal half-life being 102 + 18 minutes. 
The plasma clearance was 43 L/hr in human patients (Goodwin et al., 1995). ATO also 
has been used in infertility treatments to decrease spontaneous uterine contractions that 
could possibly expel in-vitro fertilized embryos that are transferred to women. Pierzynski 
et al. (2007) infused ATO (6.75 mg bolus, 1-hour infusion at 18 mg/h and a 2-hour 
infusion of 18 mg/h) during embryo transfer and successfully implanted two fertile 
embryos that resulted in a pregnancy.  The interpretation was that ATO efficiently 
lowered the uterine contractions and allowed the embryos to implant instead of being 
expelled (Pierzynski et al., 2007). 
Another tocolytic is barusiban (FE 20040), which was developed in Copenhagen, 
Denmark, by Ferring Pharmaceuticals. Barusiban has a 300-fold greater binding affinity 
for the human cloned OT receptor than for the V1a receptor (Reinheimer et al., 2005) 




when compared to beta-mimetic agents. Reinheimer and others (2005) concluded that 
both antagonists had a high efficacy, with 96 to 98% inhibition of intrauterine pressure in 
OT-infused cynomologus monkeys.  The onset of action and efficacy of each antagonist 
were not different; however, the duration of action was significantly longer when 
infusing barusiban compared to atosiban (Reinheimer et al., 2005). The half-life of b 
arusiban was 1.5 to 2.6 h compared to the 0.5 to 0.7 hours for Atosiban (Reinheimer et 
al., 2005). 
 Heus et al. (2008) found differences between treatment of ATO and ritodine in the 
maternal blood pressure (MBP), maternal heart rate (MHR), intra-uterine pressure or fetal 
heart rate (FHR). Ritodine-treated patients showed a rise in MHR while the MHR 
remained unaltered in the ATO-treated group. There was no significant change in the 
systolic or diastolic blood pressure in either group. The FHR rose in the ritodine group to 
11.6 bpm compared to the 4.9 bpm in the ATO-treated group. 
 Reinheimer et al. (2007) completed the comparison between barusiban and 
atosiban in the cynomologus monkey. Oxytocin was given to pregnant monkeys to 
induce contractions and simulate pre-term labor. Atosiban and barusiban were 
administered intravenously with bolus or infusion to investigate changes in the response 
of the uterine contractions. Both antagonists had a high efficacy (96-98%) of inhibition of 
intrauterine pressure and barusiban had a quicker response time being 3 to 4 times more 






Statement of the problem 
 Research concerning ovulation, luteinization and mechanisms that control the CL 
has lead researchers to investigate the effect of oxytocin on the CL, primarily in sheep 
and cattle. Results from Armstrong and Hansel (1959) and Sheldrick et al. (1980) led 
researchers at West Virginia University to investigate the role of oxytocin by treatment 
with an antagonist directly on the ovine CL. 
Mankey (2009) investigated the effects of atosiban, a combined vasopressin 1A 
and oxytocin receptor antagonist, delivered by an osmotic mini-pump, on the function of 
the ovine CL and the response to prostaglandin F2!. Atosiban, regardless of dosage, did 
not alter the decrease in serum progesterone or weight of the CL after an injection of 
PGF2!. However, progesterone appeared to decrease before the treatment with PGF2! in 
ewes receiving atosiban. In a second experiment, progesterone concentrations were 
decreased during a 48-hour sampling period when 5 !g/h of atosiban was continuously 
delivered by the mini-pump, but progesterone in CL did not decrease.  
 The main objective of the current experiment was to determine the effects of 
atosiban administered systemically. The first objective was to determine if atosiban 
administered in four systemic bolus injections had an effect on concentrations of serum 
progesterone and if the effect observed by Mankey was confirmed, to examine luteal 
function in more detail. Blood samples were drawn from a posterior vena cava catheter 
(Benoit and Dailey, 1991) every 15 minutes for 8 hours from mid-cycle (days 8 to 10) 





Material and Methods 
The study was conducted in August and September 2010 on the West Virginia 
University Animal Science Farm. A total of 24 non-lactating ewes of predominantly 
Suffolk breeding were assigned at random to treatments. Ewes were fed corn silage 
during the estrous detection period and prior to catheterization; after catheterization the 
ewes were provided mixed grass hay until blood sampling. The experimental protocol 
was approved by the West Virginia University Animal Care and Use Committee 
(protocol number 08-0501). 
Estrous detection began August 1 on a larger group of ewes (n = 36) and was 
continued until cycles were recorded on a sufficient number of ewes to begin the 
experiment. Ewes were housed in an open-sided research barn and were checked for 
estrus twice daily with the use of vasectomized rams, fitted with a crayon marking 
harness. A vasectomized ram was in constant contact with the ewes during the pre-
experimental period, and after ewes were marked, they were rechecked with another 
vasectomized ram to confirm standing estrus. Ewes were required to exhibit a complete 
estrous cycle of normal length (~16 days) prior to beginning the experiment. Ewes were 
between days 8 and 10 post estrus at the time the experiment was initiated. Replicates 
consisted of 5 to 8 ewes depending on the numbers observed in standing heat during a 
two-day period. After allocation into treatment groups, posterior vena cava catheters were 
inserted into the ewes at a depth of 65 cm. Ewes were then housed in a smaller pen and 
provided with free choice water and mixed grass hay until the start of the treatments. 





Ewes were haltered, secured to a fence in the barn period and offered water 
halfway through the experiment. The blood sampling began one hour before treatment 
and continued for nine hours, every fifteen minutes. Six mL of blood was obtained at 
each time point, and the catheter was flushed with heparinized saline after each sample. 
Blood was transferred from the syringe into a heparinized 13 x 100 mm disposable 
sample tube (Fisher Scientific) and placed on ice until plasma was removed and placed in 
15 x 45 mm sample vials  (Fisher Scientific, ). Vials were stored in a  -20 degree freezer 
until further processing. Treatments consisted of four jugular injections of either 0, 5, 10, 
20 mg of ATO, an hour apart over 3 hours (0, 1, 2 and 3 h).  Atosiban was weighed out 
one day prior to the experiment and dissolved into 3 mL of phosphate buffered saline 
(PBS) for the treatment injections. 
After blood sampling, the ewes were given one half hour to consume hay and 
water and were then placed in a dry pen for preparation for ovariectomy (OVX). Ewes 
were shorn and taken to the Food Animal Research Facility (FARF) for OVX; one final 
blood sample was obtained prior to OVX at 24 hours after the first injection of ATO. 
Ovaries were removed and the CL was excised and cut into four pieces and frozen. For 
the OVX procedure, see Foradori et al; (2005); isoflurane was used instead of halothane 
as an anesthetic. Ewes were observed during recovery, received post-operative antibiotic 
treatments at the FARF and were returned to the research barn after 24 hours.  
Radioimmunoassay was performed on all plasma samples (n = 37 per ewe) to 
measure concentrations of progesterone. Intra- and inter- assay coefficients of variance 
were 4.6% and 2.6% respectively. The standard curve ranged from 0.1 to 8.0 ng/mL, and 




39.8 ng/mL, with most samples < 6 ng/mL. Indicating that even at 65 cm (Benoit and 
Dailey, 1991 had used 56 cm in smaller ewes) the catheters were usually allowing 
sampling of blood prior to entry of ovarian drainage into the posterior vena cava. 
Statistics 
Data for concentrations of plasma progesterone were analyzed using Proc 
GLM procedure (SAS Institute; Cary, NC:9:2), with log10 transformation of progesterone 
values to account for the heterogeneity of variance of the values. The model tested the 
effects of dose of ATO, animal within dose, and the dose by time interaction. A dose by 
time interaction was observed (P < 0.001); therefore, orthogonal contrasts were made of 
the control (0 mg) to the treatments (5, 10, and 20 mg), the lower doses (5 and 10 mg) to 
the high dose (20 mg) and the low doses (5 and 10 mg) to each other. Pre-treatment 
progesterone values and end of experiment weights of CL were used as covariates in the 
comparisons to adjust for the effects of those variables on progesterone values. 
Comparisons were made separately during the treatment (time 0 to 240 minutes) (1 hour 
after last treatment) and post-treatment from (greater than time 240 until the 24 h).  
Results 
Corpus Luteum Weight 
Weights of CL from ewes treated with 5 or 10 mg of atosiban differed 
significantly (P < 0.03). However, there was no significant difference between the mean 






Figure 1. Mean corpus luteum weight (± SEM) showing effect of atosiban. Bars 
represent treatment group means (n = 6) for control, 5, 10 or 20 mg of atosiban. There 
were significant differences the between 5 and 10 mg dosages (P < 0.03). 
 
Treatment phase effects on progesterone concentration 
   The concentrations of progesterone in the control ewes differed (P < 0.0001) 
from ewes treated with 5, 10 or 20 mg of atosiban. In addition concentrations of 
progesterone differed between the 20 mg dose and the 5 and 10 mg doses together (P < 





Figure 2. Mean log10 concentrations of progesterone (± SEM). Bars represent treatment 
group means (n = 6) for control, 5, 10 or 20 mg of atosiban. There was a significant 
difference between ewes treated (5, 10 or 20 mg) with atosiban to control ewes (P < 
0.0001) also when comparing the 20 mg dose to the 5 and 10 mg doses (P < 0.05). 
 
 Considered together, these comparisons show that there was a decrease in the 
mean progesterone for ewes treated with 5, 10 or 20 mg of atosiban compared to the 
control mean. However, when comparing the treatment groups, 10 and 20 mg of atosiban 
decreased the mean progesterone concentrations when compared to the control and the 5 
mg dose. The 10 and 20 mg dosages of atosiban were the most effective in lowering 






Post treatment effects on progesterone concentration 
There were differences during this time interval comparing the controls to all 
treated groups (P < 0.005), and ewes treated with 20 mg versus 5 and 10 mg (P < 0.05, 
Figure 3). 
 
Figure 3. Mean log10 concentrations of progesterone (± SEM). Bars represent treatment 
group means (n = 6) for control, 5, 10 or 20 mg of atosiban. There were significant 
differences for control versus treatment (0 mg vs 5, 10 and 20 mg) (P < 0.005), and 
between the high dose versus the lower dosages (20 mg vs 5 and 10 mg) (P < 0.05). 
 
During this time interval the mean log10 progesterone concentration of the control 
ewes decreased (1.04) compared to the treatment interval (1.07).  There was an increase 
(1.02 vs. 0.99) in the mean log10 progesterone concentrations of the ewes treated with 10 




the control ewes during the post-treatment period. The lowest progesterone concentration 
was seen in the group treated with 20 mg of atosiban. 
Overall effect of dose on progesterone concentration 
 When analyzing the overall effect of atosiban on progesterone concentrations 
from time 0 until the end of the experiment, there was a significant difference when 
comparing the control ewes to the ewes treated with (5, 10 or 20 mg) of atosiban (P < 
0.0001, Figure 4). 
 
Figure 4. Mean log10 concentrations of progesterone (± SEM). Bars represent treatment 
group means (n = 6) for control, 5, 10 or 20 mg of atosiban. There were significant 







  The major hormone in reproduction and the maintenance of pregnancy is 
progesterone (Murphy, 2000), produced by the CL. Current research is centered around 
progesterone production, CL lifespan, and endocrine/exocrine factors that control the CL. 
One factor proposed to affect progesterone production is oxytocin. Atosiban is a 
combined oxytocin and vasopressin receptor antagonist, which was used in this 
experiment to test the proposed mechanisms by which oxytocin might influence 
progesterone secretion as measured by its concentration in the posterior vena cava of 
ewes. Intravenous injections of atosiban had a significant effect on log10 concentrations 
of progesterone, both during and after treatment. There were similar effects during and 
after treatment log10 concentrations of progesterone. Mean progesterone concentrations 
were reduced in ewes treated with (5, 10 or 20 mg) atosiban compared to the control 
ewes. The observed reduction in progesterone fits with the earlier study by Mankey 
(2009), who infused atosiban directly into the CL. Thus, the current data confirmed the 
hypothesis that atosiban reduced the progesterone in response to treatment. 
 During the post treatment phase there was a decrease in the progesterone in the 
control ewes and an increase in the concentration of progesterone in ewes treated with 10 
mg of atosiban compared to during treatment. However, mean progesterone 
concentrations for all treated groups remained lower post treatment than in the control 
group. Nevertheless, there was a rebound in the concentration of progesterone from 




 Atosiban has been found to be a “biased agonist” when cultured with human 
oxytocin receptors (Reversi et al., 2005). Human oxytocin receptors have been shown to 
associate to Gq, Gi and Gs proteins (Strakova & Soloff, 1997). Coupling to Gq is 
responsible for phospholipase C activation, which is responsible for increased 
intracellular calcium (Sanborn, 2001). Atosiban acted as a competitive antagonist on the 
oxytocin receptor/Gq coupling and displayed agonistic properties on the OTR/Gi pathway, 
but no effects on the OTR/Gs pathway. However, atosiban lead to persistent ERK1/2 
activation and p
21
 induction and inhibited oxytocin-cell growth in kidney cells and 
prostate cells infected with oxytocin receptors (Reversi et al., 2005).  
Similar to atosiban, oxytocin has demonstrated two different mechanisms of 
action. A low concentration of 4 i.u/mL oxytocin stimulated progesterone production 
when cultured with 10 i.u/mL of hCG on human luteal cells (Tan et al., 1982). However, 
400 or 800 i.u/mL of oxytocin inhibited progesterone production in the same system. In 
contrast, Richardson and Masson (1985) incubated bovine luteal cells with 10 i.u/mL of 
hCG and 500 i.u/mL of oxytocin and progesterone production was not inhibited. 
 Lutz and others (1991) used mini-pumps or jugular infusions of oxytocin to the 
CL beginning on day 10 and observed lengthened diestrus as a result of prolonged 
progesterone secretion. In saline-infused heifers normal PGF2! secretion occurred on day 
16 in response to a challenge injection of oxytocin. These results demonstrated that 
chronic oxytocin treatment inhibited episodic pulses of PGF2!. Miyamoto and Schams 
(1991) utilized a microdialysis system in bovine CL and found that the combination of 
bovine LH and oxytocin stimulated progesterone secretion in a dose dependent manner. 




from day 8 to 18. Their overall interpretation of the results was that cell-to-cell 
interactions were needed for progesterone to be stimulated by oxytocin (Miyamoto and 
Schams, 1991). 
Atosiban could have vasoconstrictive properties, which was not measured in the 
experiment. In the previous study (Mankey, 2009) did not find a difference in luteal 
progesterone, but found a difference in circulating concentrations of progesterone. 
Oxytocin has been found to be a vasoconstrictor in rats (Altura and Altura, 1977). 
Another source of vasoconstriction could be from arginine vasopressin activation, which 
is a known vasocontrictor (Du Vigneaud et al., 1953). Bovine CL produced arginine 
vasopressin (Wathes et al., 1983). When porcine and bovine luteal cells were cultured 
separately with either oxytocin or vasopressin; the vasopressin was more effective at 
reducing progesterone concentrations than oxytocin (Pitzel et al., 1988). 
In general, the roles of oxytocin are not fully understood in any species. This 
uncertainty is further displayed by the previous experiment conducted by Mankey (2009). 
When atosiban was delivered directly into the CL via a mini-osmotic pump it appeared to 
decrease progesterone. However, there was not a significant difference among doses of 
atosiban in progesterone concentrations after an injection of PGF2!. In a second 
experiment, the negative effect of atosiban on progesterone was confirmed. Progesterone 
concentrations were decreased significantly during the 48-hour sampling period when 5 
!g/h of atosiban was continuously delivered via mini-pump. 
The results of the current study are similar to those found by Mankey (2009). A 




both studies. The differences in dose and route of administration did not appear to alter  
the outcome of the present study. The previous study used an osmotic-mini-pump to 
deliver the atosiban directly into the CL and delivered the doses constantly for 14 days. 
However, in the current study, the treatments were delivered via bolus intravenous 
injections every hour for four hours beginning with time zero and stopping at time 180 
minutes. When comparing the dose amounts from the two experiments, the previous 
experiment used a lower amount of atosiban than did the current experiment. The 
increased dose was chosen on the basis of human research in which was used to halt 
uterine contractions. 
The “biased agonist” theory could be used to explain the results from this 
experiment. Perhaps one dose of atosiban can be an agonist while another dose can be an 
antagonist. During the treatment phase of the experiment, progesterone decreased in the 
treated groups. Only in the 10 mg group, progesterone increased in the post treatment 
phase compared to the treatment phase. The degree of progesterone suppression was less 
in the post treatment period in the ewes treated with 10 mg of atosiban compared to the 
ewes treated with 5 or 20 mg. The present results, are similar to those of Mankey (2009) 
in terms of the overall the reduction in progesterone concentrations. 
Conclusion 
 The main conclusion from this experiment is that atosiban reduced circulating 
concentrations of progesterone. Examination of the mechanism for this effect will require 




progesterone in the CL did not change. It also will be appropriate to examine changes in 
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